Bacillus subtilis BSC35 spores are investigated for its ability, during germination, to produce a bacteriocin-like inhibitory substance (BLIS) against Clostridioides difficile and Clostridium perfringens, and its sporulation medium is optimized. In Ch...
Bacillus subtilis BSC35 spores are investigated for its ability, during germination, to produce a bacteriocin-like inhibitory substance (BLIS) against Clostridioides difficile and Clostridium perfringens, and its sporulation medium is optimized. In Chapter Ⅰ, the cell-free supernatant (CFS) of B. subtilis BSC35 is shown to exhibit quantifiable and reproducible antibacterial activity against both Clostridioides difficile and Clostridium perfringens. Despite inherent variability in inhibition zone diameters among C. perfringens strains reported in previous studies, BLIS BSC35 consistently inhibited two phylogenetically distinct pathogens, suggesting cross-genus activity uncommon among Bacillus-derived bacteriocins. Transmission electron microscopy of CFS-treated C. difficile revealed disrupted cell walls, compromised membranes, and cytoplasmic leakage, indicating a bactericidal mechanism. Medium composition significantly influenced sizes of inhibition zone by BLIS; CFS derived from DSM medium exhibited reduced inhibition compared with TSB-derived CFS, implying medium composition-dependent BLIS production or stability. Notably, BSC35 spores successfully germinated and produced BLIS under aerobic and anaerobic conditions, highlighting their potential for gastrointestinal applications where oxygen availability is limited. The B. subtilis BSC35 CFS concentration-dependent antibacterial activity observed in liquid culture further confirmed that BLIS production is intrinsic to BSC35 and not due to medium carryover. Although the chemical identity of BLIS remains to be elucidated, its dual activity against C. difficile and C. perfringens underscores its potential as a candidate for gut-targeted biocontrol strategies.
In Chapter Ⅱ, a stepwise optimization strategy incorporating One Variable At a Time (OVAT), Plackett-Burman Design (PBD), and Central Composite Design (CCD) was employed to maximize spore production of B. subtilis BSC35. OVAT screening identified molasses and yeast extract as the most effective carbon and complex nutrient sources, respectively, while soybean flour and corn steep liquor were the most effective nitrogen sources. Among inorganic salts, MgSO4 and NaCl positively influenced spore formation. PBD analysis confirmed yeast extract, molasses, soybean flour, corn steep liquor, and NaCl as significant contributors to spore yield. CCD-based response surface modeling produced a highly significant regression model (P < 0.0001) with excellent predictive accuracy (R2 = 0.9359, Adj. R2 = 0.8986, CV = 1.08%). A significant interaction between yeast extract and soybean flour indicated a synergistic effect on spore production. Validation experiments using shake flasks and a 5 L bioreactor confirmed the accuracy of the optimized medium, with spore yields closely matching model predictions and demonstrating scalability of the optimized formulation. The optimized medium, composed of cost-effective ingredients compared with conventional TSB, increased spore production from 4.1×107 CFU/mL to 4.71×109 CFU/mL.
In addition, freeze-drying experiments demonstrated that appropriate protectant formulations, particularly combinations of skim milk and sucrose, markedly improved spore survival, supporting the stability and feasibility of BSC35 spores for long-term storage and industrial application. Together, these findings highlight the potential of B. subtilis BSC35 as a scalable, economically viable, and formulation-ready candidate for gut-targeted biocontrol strategies.
Overall, B. subtilis BSC35 spores produce a bacteriocin-like inhibitory substance (BLIS) during germination, showing bactericidal activity against C. difficile and C. perfringens, with production influenced by medium composition and effective under both aerobic and anaerobic conditions. Stepwise medium optimization using OVAT, PBD, and CCD significantly enhanced spore yields, with key nutrients identified and scalability confirmed in shake flasks and a 5 L bioreactor, supporting potential applications for gut-targeted biocontrol.